Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 26, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,084,130

« Back to Dashboard

Which drugs does patent 7,084,130 protect, and when does it expire?

Patent 7,084,130 protects NAVSTEL and is included in one NDA.

This patent has twenty patent family members in sixteen countries.

Summary for Patent: 7,084,130

Title:	Intraocular irrigating solution having improved flow characteristics
Abstract:	Improved intraocular irrigating solutions are described. The solutions have enhanced viscosities that reduce the risk of damage to intraocular surgical procedures by reducing the turbulence of the solutions and dampening the movement of tissue fragments and air bubbles. The solutions preferably also have modified surface tensions that more closely resemble the surface tension of the aqueous humor.
Inventor(s):	Shah; Mandar V. (Arlington, TX), Boukhny; Mikhail (Laguna Niguel, CA), Garner; William H. (Southlake, TX), Markwardt; Kerry L. (Mansfield, TX), Doshi; Uday (Randolph, NJ)
Assignee:	Alcon, Inc. (Hunenberg, CH)
Application Number:	10/240,449
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 7,084,130
Patent Claim Types: see list of patent claims	Composition; Formulation; Use;

Drugs Protected by US Patent 7,084,130

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Alcon Pharms Ltd	NAVSTEL	calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	SOLUTION;IRRIGATION	022193-001	Jul 24, 2008		DISCN	No	No	➤ Sign Up	➤ Sign Up	Y			USE AS AN INTRAOCULAR IRRIGATING SOLUTION DURING SURGICAL PROCEDURES INVOLVING PERFUSION OF THE EYE	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 7,084,130

PCT Information
PCT Filed	December 11, 2001	PCT Application Number:	PCT/US01/48094
PCT Publication Date:	June 27, 2002	PCT Publication Number:	WO02/49614

International Family Members for US Patent 7,084,130

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	459337	➤ Sign Up
Australia	2002239601	➤ Sign Up
Australia	3960102	➤ Sign Up
Brazil	0116353	➤ Sign Up
Canada	2431368	➤ Sign Up
Cyprus	1110703	➤ Sign Up
Germany	60141477	➤ Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.